DBV Technologies | DBVT - EPS Earnings Per Share

Stock Price
21.94
Daily Change
0.71 3.32%
Monthly
-4.09%
Yearly
435.00%
Q1 Forecast
20.91

DBV Technologies reported $-0.24 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.





Eps Change Date
Acadia Pharmaceuticals USD 0.42 0.26 Sep/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amarin USD 0.08 0.11 Sep/2025
BioCryst Pharmaceuticals USD -0.13 0.06 Dec/2024
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
DBV Technologies USD -0.24 1.31 Sep/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Galectin Therapeutics USD -0.2 0.01 Jun/2024
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Incyte USD 1.8 0.46 Dec/2025
Insmed USD -1.54 0.21 Dec/2025
Ionis Pharmaceuticals USD -0.8 1.5 Sep/2025
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Sarepta Therapeutics USD -0.13 2.15 Sep/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
United Therapeutics USD 7.16 0.75 Sep/2025